GR80445B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GR80445B GR80445B GR80445A GR840180445A GR80445B GR 80445 B GR80445 B GR 80445B GR 80445 A GR80445 A GR 80445A GR 840180445 A GR840180445 A GR 840180445A GR 80445 B GR80445 B GR 80445B
- Authority
- GR
- Greece
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838325494A GB8325494D0 (en) | 1983-09-23 | 1983-09-23 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR80445B true GR80445B (en) | 1985-01-23 |
Family
ID=10549200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR80445A GR80445B (en) | 1983-09-23 | 1984-09-21 | Pharmaceutical compositions |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4666927A (el) |
| EP (2) | EP0357150B1 (el) |
| JP (2) | JPH062739B2 (el) |
| CY (1) | CY1516A (el) |
| DE (2) | DE3486255T2 (el) |
| DK (1) | DK158349C (el) |
| GB (2) | GB8325494D0 (el) |
| GR (1) | GR80445B (el) |
| SG (1) | SG80989G (el) |
| ZA (1) | ZA847408B (el) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| US4780238A (en) * | 1983-08-25 | 1988-10-25 | The United States Of America As Represented By The United States Department Of Energy | Natural chelating agents for radionuclide decorporation |
| US5010191A (en) * | 1985-08-19 | 1991-04-23 | The Regents Of The University Of California | Imaging agents for in vivo magnetic resonance and scintigraphic imaging |
| US4908371A (en) * | 1987-11-10 | 1990-03-13 | Ciba-Geigy Corporation | Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload |
| GB8910521D0 (en) * | 1989-05-08 | 1989-06-21 | Nat Res Dev | The stabilization of organic compounds |
| US5393777A (en) * | 1990-11-15 | 1995-02-28 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University | Deferration using anguibactin siderophore |
| WO1992013841A1 (de) * | 1991-02-08 | 1992-08-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Komplexbildner |
| EP0648209A1 (de) * | 1992-07-01 | 1995-04-19 | Byk Gulden Lomberg Chemische Fabrik GmbH | Kontrastmittel für die mr diagnostik |
| US5298525A (en) * | 1992-11-23 | 1994-03-29 | University Technologies International, Inc. | Diabetes prevention and treatment |
| US5849587A (en) * | 1995-06-09 | 1998-12-15 | Cornell Research Foundation, Inc. | Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| ES2230564T3 (es) | 1995-06-10 | 2005-05-01 | Vitra Pharmaceuticals Ltd. | Compuestos ferricos, composiciones, metodos de fabricacion de estos y sus utilizacioneds. |
| ES2221929T3 (es) * | 1995-06-14 | 2005-01-16 | The Regents Of The University Of California | Agentes quelantes 3-hidroxi-2(1h)-piridinona. |
| US7026116B1 (en) * | 1996-04-04 | 2006-04-11 | Bio-Rad Laboratories, Inc. | Polymorphisms in the region of the human hemochromatosis gene |
| US6140305A (en) * | 1996-04-04 | 2000-10-31 | Bio-Rad Laboratories, Inc. | Hereditary hemochromatosis gene products |
| US6849399B1 (en) | 1996-05-23 | 2005-02-01 | Bio-Rad Laboratories, Inc. | Methods and compositions for diagnosis and treatment of iron misregulation diseases |
| ZA976421B (en) * | 1996-07-22 | 1998-01-22 | Boehringer Mannheim Italia | New bis-platinum complexes with polyamine ligands as antitumor agents. |
| GB9625638D0 (en) * | 1996-12-10 | 1997-01-29 | Cenes Ltd | Therapeutic antioxidants for alzheimer's diease |
| ATE462717T1 (de) | 1997-06-13 | 2010-04-15 | Bio Rad Laboratories | Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind |
| GB2345058A (en) * | 1998-12-01 | 2000-06-28 | Cerebrus Pharm Ltd | Hydroxypyridone compounds useful in the treatment of oxidative damage to the central nervous system |
| US6767741B1 (en) | 1999-08-27 | 2004-07-27 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
| AU2001287850A1 (en) * | 2000-09-19 | 2002-04-02 | Vitra Pharmaceuticals Limited | Iron compositions |
| US6846915B2 (en) | 2001-08-13 | 2005-01-25 | The Regents Of The University Of California | Hydroxypyridonate and hydroxypyrimidinone chelating agents |
| GB0211500D0 (en) | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
| US7595073B2 (en) * | 2003-02-28 | 2009-09-29 | Kraft Foods Global Brands Llc | Use of siderophores and organic acids to retard lipid oxidation |
| GB0425555D0 (en) * | 2004-11-19 | 2004-12-22 | Glaxo Group Ltd | Novel compounds |
| AU2007272604B2 (en) | 2006-07-10 | 2013-08-01 | The Regents Of The University Of California | Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides |
| US9259670B2 (en) | 2008-04-16 | 2016-02-16 | The University Of Kentucky Research Foundation | Flow-through filter to remove aluminum from medical solutions |
| US7932326B2 (en) * | 2008-04-16 | 2011-04-26 | The University Of Kentucky Research Foundation | Chelating compounds and immobilized tethered chelators |
| US9139456B2 (en) | 2008-04-16 | 2015-09-22 | The Curators Of The University Of Missouri | Chelating compounds and immobilized tethered chelators |
| US20100008864A1 (en) * | 2008-07-10 | 2010-01-14 | Andreas Meijer | Aromatic multimers |
| EP2816038B8 (en) | 2009-08-24 | 2019-12-25 | Lumiphore, Inc. | Hopo chelators |
| WO2011079291A1 (en) * | 2009-12-24 | 2011-06-30 | Lumiphore, Inc. | Radiopharmaceutical complexes |
| US11453652B2 (en) | 2013-03-15 | 2022-09-27 | Lumiphore, Inc. | Di-macrocycles |
| CN106928132B (zh) * | 2017-02-23 | 2020-07-24 | 苏州大学 | 一种羟基吡啶酮配体及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3968118A (en) * | 1968-08-31 | 1976-07-06 | Hoechst Aktiengesellschaft | Process for the manufacture of 1-hydroxy-2-pyridones |
| CA1049411A (en) * | 1972-12-18 | 1979-02-27 | Affiliated Medical Research | N-substituted pyridone and general method for preparing pyridones |
| GR78491B (el) * | 1982-03-24 | 1984-09-27 | Nat Res Dev | |
| CY1501A (en) * | 1982-03-24 | 1990-08-03 | Nat Res Dev | Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or-4-one derivatives |
| GB2118176B (en) * | 1982-03-24 | 1985-12-04 | Nat Res Dev | Pharmaceutical compositions |
-
1983
- 1983-09-23 GB GB838325494A patent/GB8325494D0/en active Pending
-
1984
- 1984-09-18 US US06/651,684 patent/US4666927A/en not_active Expired - Fee Related
- 1984-09-20 DE DE89202213T patent/DE3486255T2/de not_active Expired - Fee Related
- 1984-09-20 CY CY1516A patent/CY1516A/xx unknown
- 1984-09-20 EP EP89202213A patent/EP0357150B1/en not_active Expired - Lifetime
- 1984-09-20 ZA ZA847408A patent/ZA847408B/xx unknown
- 1984-09-20 DE DE8484306438T patent/DE3483713D1/de not_active Expired - Lifetime
- 1984-09-20 EP EP84306438A patent/EP0138421B1/en not_active Expired - Lifetime
- 1984-09-20 GB GB08423799A patent/GB2146989B/en not_active Expired
- 1984-09-21 GR GR80445A patent/GR80445B/el unknown
- 1984-09-21 DK DK453684A patent/DK158349C/da not_active IP Right Cessation
- 1984-09-25 JP JP59201408A patent/JPH062739B2/ja not_active Expired - Lifetime
-
1989
- 1989-12-12 JP JP1324877A patent/JPH062740B2/ja not_active Expired - Lifetime
- 1989-12-16 SG SG809/89A patent/SG80989G/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA847408B (en) | 1986-05-28 |
| EP0357150A1 (en) | 1990-03-07 |
| EP0357150B1 (en) | 1993-12-08 |
| DE3483713D1 (de) | 1991-01-17 |
| GB8325494D0 (en) | 1983-10-26 |
| JPH02191254A (ja) | 1990-07-27 |
| GB2146989B (en) | 1987-02-18 |
| JPH062739B2 (ja) | 1994-01-12 |
| DK453684D0 (da) | 1984-09-21 |
| JPS6094965A (ja) | 1985-05-28 |
| SG80989G (en) | 1990-07-06 |
| DE3486255T2 (de) | 1994-03-24 |
| US4666927A (en) | 1987-05-19 |
| JPH062740B2 (ja) | 1994-01-12 |
| EP0138421B1 (en) | 1990-12-05 |
| GB8423799D0 (en) | 1984-10-24 |
| GB2146989A (en) | 1985-05-01 |
| EP0138421A2 (en) | 1985-04-24 |
| DK158349B (da) | 1990-05-07 |
| DK453684A (da) | 1985-03-24 |
| EP0138421A3 (en) | 1987-06-03 |
| DE3486255D1 (de) | 1994-01-20 |
| CY1516A (en) | 1990-08-03 |
| DK158349C (da) | 1990-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2136807B (en) | Pharmaceutical compositions | |
| GB8423339D0 (en) | Pharmaceutical compositions | |
| GB8403668D0 (en) | Pharmaceutical compositions | |
| DE3467703D1 (en) | Pharmaceutical compositions | |
| GB8412108D0 (en) | Pharmaceutical compositions | |
| GB8415975D0 (en) | Pharmaceutical compositions | |
| ZA847408B (en) | Pharmaceutical compositions | |
| GB8308126D0 (en) | Pharmaceutical compositions | |
| GR80444B (en) | Pharmaceutical compositions | |
| GB8329043D0 (en) | Pharmaceutical compositions | |
| GB2136806B (en) | Pharmaceutical compositions | |
| GB8414458D0 (en) | Pharmaceutical compositions | |
| CY1503A (en) | Pharmaceutical compositions | |
| GB8412569D0 (en) | Pharmaceutical compositions | |
| GR80223B (en) | Pharmaceutical compositions | |
| GB8406132D0 (en) | Pharmaceutical compositions | |
| GB8419243D0 (en) | Pharmaceutical compositions | |
| GB8416358D0 (en) | Pharmaceutical compositions | |
| GB8305697D0 (en) | Pharmaceutical compositions | |
| GB8300767D0 (en) | Pharmaceutical compositions | |
| GB8425250D0 (en) | Pharmaceutical compositions | |
| GB2150435B (en) | Pharmaceutical compositions | |
| GB8331425D0 (en) | Pharmaceutical compositions | |
| GB8304870D0 (en) | Pharmaceutical compositions | |
| GB8301718D0 (en) | Pharmaceutical compositions |